nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2E1—Parkinson's disease	0.848	1	CbGaD
Alosetron—HTR3A—enteric nervous system—Parkinson's disease	0.0321	0.394	CbGeAlD
Alosetron—HTR3A—myenteric nerve plexus—Parkinson's disease	0.0243	0.299	CbGeAlD
Alosetron—HTR3A—nerve—Parkinson's disease	0.00633	0.0778	CbGeAlD
Alosetron—Ondansetron—HTR1A—Parkinson's disease	0.00429	0.414	CrCbGaD
Alosetron—Ondansetron—CYP2E1—Parkinson's disease	0.0035	0.338	CrCbGaD
Alosetron—HTR3A—brainstem—Parkinson's disease	0.00272	0.0334	CbGeAlD
Alosetron—HTR3A—forebrain—Parkinson's disease	0.00262	0.0322	CbGeAlD
Alosetron—Ondansetron—CYP2D6—Parkinson's disease	0.00257	0.248	CrCbGaD
Alosetron—HTR3A—head—Parkinson's disease	0.0015	0.0184	CbGeAlD
Alosetron—HTR3A—nervous system—Parkinson's disease	0.00142	0.0175	CbGeAlD
Alosetron—HTR3A—central nervous system—Parkinson's disease	0.00137	0.0168	CbGeAlD
Alosetron—HTR3A—brain—Parkinson's disease	0.00109	0.0134	CbGeAlD
Alosetron—CYP2C9—cardiovascular system—Parkinson's disease	0.00109	0.0133	CbGeAlD
Alosetron—CYP2E1—cardiovascular system—Parkinson's disease	0.00103	0.0126	CbGeAlD
Alosetron—CYP2E1—medulla oblongata—Parkinson's disease	0.000879	0.0108	CbGeAlD
Alosetron—CYP2E1—spinal cord—Parkinson's disease	0.000784	0.00964	CbGeAlD
Alosetron—CYP2E1—head—Parkinson's disease	0.000697	0.00856	CbGeAlD
Alosetron—CYP2E1—nervous system—Parkinson's disease	0.00066	0.00812	CbGeAlD
Alosetron—CYP2E1—central nervous system—Parkinson's disease	0.000636	0.00782	CbGeAlD
Alosetron—CYP2E1—cerebellum—Parkinson's disease	0.000622	0.00764	CbGeAlD
Alosetron—CYP3A4—nervous system—Parkinson's disease	0.000531	0.00653	CbGeAlD
Alosetron—CYP3A4—central nervous system—Parkinson's disease	0.000512	0.00629	CbGeAlD
Alosetron—CYP2E1—brain—Parkinson's disease	0.000505	0.00621	CbGeAlD
Alosetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00036	0.00599	CbGpPWpGaD
Alosetron—CYP1A2—Tryptophan metabolism—MAOB—Parkinson's disease	0.000355	0.00591	CbGpPWpGaD
Alosetron—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000355	0.00591	CbGpPWpGaD
Alosetron—CYP2E1—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000351	0.00583	CbGpPWpGaD
Alosetron—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000349	0.0058	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00034	0.00565	CbGpPWpGaD
Alosetron—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.000327	0.00544	CbGpPWpGaD
Alosetron—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000326	0.00542	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000323	0.00537	CbGpPWpGaD
Alosetron—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000323	0.00537	CbGpPWpGaD
Alosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000308	0.00511	CbGpPWpGaD
Alosetron—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000299	0.00498	CbGpPWpGaD
Alosetron—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000295	0.0049	CbGpPWpGaD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000288	0.00479	CbGpPWpGaD
Alosetron—CYP1A2—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000288	0.00478	CbGpPWpGaD
Alosetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000281	0.00467	CbGpPWpGaD
Alosetron—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000274	0.00456	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000273	0.00453	CbGpPWpGaD
Alosetron—CYP1A2—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000268	0.00445	CbGpPWpGaD
Alosetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00025	0.00415	CbGpPWpGaD
Alosetron—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000247	0.0041	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000242	0.00402	CbGpPWpGaD
Alosetron—CYP1A2—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000242	0.00402	CbGpPWpGaD
Alosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00024	0.00399	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.000239	0.00397	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.000239	0.00397	CbGpPWpGaD
Alosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000238	0.00395	CbGpPWpGaD
Alosetron—CYP1A2—Phase II conjugation—GSTA4—Parkinson's disease	0.000237	0.00394	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000233	0.00387	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—GSTA4—Parkinson's disease	0.000231	0.00384	CbGpPWpGaD
Alosetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000229	0.0038	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000228	0.00379	CbGpPWpGaD
Alosetron—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000226	0.00375	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000223	0.0037	CbGpPWpGaD
Alosetron—CYP1A2—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000218	0.00362	CbGpPWpGaD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000217	0.0036	CbGpPWpGaD
Alosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000214	0.00355	CbGpPWpGaD
Alosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000211	0.0035	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—MAOB—Parkinson's disease	0.000206	0.00342	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000203	0.00337	CbGpPWpGaD
Alosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000195	0.00325	CbGpPWpGaD
Alosetron—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000195	0.00323	CbGpPWpGaD
Alosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000193	0.0032	CbGpPWpGaD
Alosetron—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000192	0.00319	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000192	0.00319	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000191	0.00318	CbGpPWpGaD
Alosetron—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000186	0.0031	CbGpPWpGaD
Alosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000185	0.00308	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000185	0.00308	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00018	0.00299	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000173	0.00288	CbGpPWpGaD
Alosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000165	0.00274	CbGpPWpGaD
Alosetron—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000164	0.00273	CbGpPWpGaD
Alosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000163	0.0027	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.000162	0.0027	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00016	0.00266	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000159	0.00264	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000158	0.00263	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—CYP2D6—Parkinson's disease	0.000153	0.00254	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000152	0.00253	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000152	0.00253	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000151	0.00251	CbGpPWpGaD
Alosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000151	0.00251	CbGpPWpGaD
Alosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000149	0.00247	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000145	0.00241	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000139	0.00231	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.000139	0.00231	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000137	0.00228	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000134	0.00222	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000132	0.0022	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00013	0.00217	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000127	0.00211	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000124	0.00206	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000122	0.00203	CbGpPWpGaD
Alosetron—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000119	0.00198	CbGpPWpGaD
Alosetron—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.000119	0.00197	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—COMT—Parkinson's disease	0.000116	0.00193	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	0.000115	0.00192	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	0.000115	0.00191	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	0.000114	0.0019	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000114	0.00189	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000112	0.00187	CbGpPWpGaD
Alosetron—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000109	0.00181	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000108	0.00179	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000107	0.00178	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000106	0.00176	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	0.000106	0.00176	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000106	0.00176	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000105	0.00174	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000101	0.00167	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	9.85e-05	0.00164	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.71e-05	0.00161	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	9.61e-05	0.0016	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	9.55e-05	0.00159	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	9.2e-05	0.00153	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	9.07e-05	0.00151	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	9e-05	0.0015	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	8.41e-05	0.0014	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.3e-05	0.00138	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—COMT—Parkinson's disease	8.16e-05	0.00136	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	8.12e-05	0.00135	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	8.1e-05	0.00135	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	8.05e-05	0.00134	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	8.01e-05	0.00133	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	7.69e-05	0.00128	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ND3—Parkinson's disease	7.52e-05	0.00125	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MCCC1—Parkinson's disease	7.52e-05	0.00125	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	7.46e-05	0.00124	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	7.36e-05	0.00122	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	7.1e-05	0.00118	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—TALDO1—Parkinson's disease	7.07e-05	0.00118	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—OMD—Parkinson's disease	7.07e-05	0.00118	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	7e-05	0.00116	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—COMT—Parkinson's disease	6.97e-05	0.00116	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	6.97e-05	0.00116	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	6.97e-05	0.00116	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	6.94e-05	0.00115	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	6.92e-05	0.00115	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	6.88e-05	0.00114	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	6.84e-05	0.00114	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	6.7e-05	0.00111	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	6.49e-05	0.00108	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.4e-05	0.00106	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GCH1—Parkinson's disease	6.39e-05	0.00106	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	6.38e-05	0.00106	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	6.29e-05	0.00105	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—DBH—Parkinson's disease	5.7e-05	0.000947	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GBA—Parkinson's disease	5.7e-05	0.000947	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—FBP1—Parkinson's disease	5.7e-05	0.000947	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	5.62e-05	0.000934	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.38e-05	0.000894	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.35e-05	0.00089	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.34e-05	0.000888	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.31e-05	0.000882	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MCCC1—Parkinson's disease	5.29e-05	0.000879	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ND3—Parkinson's disease	5.29e-05	0.000879	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.28e-05	0.000878	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—OMD—Parkinson's disease	4.97e-05	0.000827	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—TALDO1—Parkinson's disease	4.97e-05	0.000827	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.92e-05	0.000818	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.85e-05	0.000807	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.8e-05	0.000798	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	4.72e-05	0.000784	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MCCC1—Parkinson's disease	4.52e-05	0.000751	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ND3—Parkinson's disease	4.52e-05	0.000751	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GCH1—Parkinson's disease	4.5e-05	0.000748	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—TALDO1—Parkinson's disease	4.25e-05	0.000706	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—OMD—Parkinson's disease	4.25e-05	0.000706	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—DDC—Parkinson's disease	4.18e-05	0.000695	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.06e-05	0.000674	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	4.03e-05	0.00067	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—DBH—Parkinson's disease	4.01e-05	0.000666	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GBA—Parkinson's disease	4.01e-05	0.000666	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—FBP1—Parkinson's disease	4.01e-05	0.000666	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTA4—Parkinson's disease	3.95e-05	0.000657	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GCH1—Parkinson's disease	3.84e-05	0.000639	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	3.56e-05	0.000591	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MAOB—Parkinson's disease	3.52e-05	0.000585	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ND3—Parkinson's disease	3.49e-05	0.00058	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.49e-05	0.00058	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.47e-05	0.000576	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—DBH—Parkinson's disease	3.43e-05	0.000569	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GBA—Parkinson's disease	3.43e-05	0.000569	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—FBP1—Parkinson's disease	3.43e-05	0.000569	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.28e-05	0.000545	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—OMD—Parkinson's disease	3.28e-05	0.000545	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.11e-05	0.000517	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.97e-05	0.000493	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—DDC—Parkinson's disease	2.94e-05	0.000489	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.78e-05	0.000462	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.74e-05	0.000456	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.64e-05	0.000439	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—DBH—Parkinson's disease	2.64e-05	0.000439	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GBA—Parkinson's disease	2.64e-05	0.000439	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	2.62e-05	0.000435	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CTGF—Parkinson's disease	2.57e-05	0.000427	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—DDC—Parkinson's disease	2.51e-05	0.000418	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	2.5e-05	0.000416	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MAOB—Parkinson's disease	2.48e-05	0.000412	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA4—Parkinson's disease	2.37e-05	0.000395	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NQO1—Parkinson's disease	2.37e-05	0.000393	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.36e-05	0.000392	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.34e-05	0.00039	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—TH—Parkinson's disease	2.33e-05	0.000388	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYCS—Parkinson's disease	2.24e-05	0.000372	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.14e-05	0.000355	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MAOB—Parkinson's disease	2.12e-05	0.000352	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.01e-05	0.000335	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—COMT—Parkinson's disease	1.98e-05	0.00033	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.97e-05	0.000328	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.97e-05	0.000327	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.95e-05	0.000324	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—DDC—Parkinson's disease	1.94e-05	0.000323	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.87e-05	0.000311	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.84e-05	0.000306	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.83e-05	0.000305	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1.81e-05	0.000301	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.81e-05	0.0003	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GPX1—Parkinson's disease	1.74e-05	0.000289	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.68e-05	0.00028	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.66e-05	0.000277	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.65e-05	0.000274	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—TH—Parkinson's disease	1.64e-05	0.000273	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.63e-05	0.000271	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MTHFR—Parkinson's disease	1.6e-05	0.000266	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.58e-05	0.000262	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.57e-05	0.000261	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.54e-05	0.000257	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—APOE—Parkinson's disease	1.49e-05	0.000248	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.44e-05	0.000239	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.42e-05	0.000236	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—TH—Parkinson's disease	1.4e-05	0.000233	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—COMT—Parkinson's disease	1.4e-05	0.000232	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.39e-05	0.000231	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.39e-05	0.00023	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.37e-05	0.000228	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.35e-05	0.000224	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.31e-05	0.000218	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.28e-05	0.000212	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—INS—Parkinson's disease	1.27e-05	0.000212	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.22e-05	0.000203	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.21e-05	0.000202	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—COMT—Parkinson's disease	1.19e-05	0.000198	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.19e-05	0.000198	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.19e-05	0.000197	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.18e-05	0.000197	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.17e-05	0.000194	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.13e-05	0.000187	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.12e-05	0.000187	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.11e-05	0.000185	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.1e-05	0.000182	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.09e-05	0.000181	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—TH—Parkinson's disease	1.08e-05	0.00018	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOE—Parkinson's disease	1.05e-05	0.000174	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.04e-05	0.000174	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.04e-05	0.000173	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTHFR—Parkinson's disease	9.64e-06	0.00016	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—COMT—Parkinson's disease	9.2e-06	0.000153	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTP1—Parkinson's disease	9.16e-06	0.000152	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MAOA—Parkinson's disease	9.14e-06	0.000152	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HMOX1—Parkinson's disease	9.03e-06	0.00015	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOE—Parkinson's disease	8.97e-06	0.000149	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—INS—Parkinson's disease	8.97e-06	0.000149	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.67e-06	0.000144	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.42e-06	0.00014	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GPX1—Parkinson's disease	8.06e-06	0.000134	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—INS—Parkinson's disease	7.66e-06	0.000127	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.44e-06	0.000124	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOE—Parkinson's disease	6.92e-06	0.000115	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—INS—Parkinson's disease	5.91e-06	9.83e-05	CbGpPWpGaD
